ALFA FinderBSE filing, BSE: 544979. Summary written from the filing by ALFA Finder's alert engine.
EverestIMS Technologies Ltd: key numbers
- Share price
- ₹86.44
- Market cap
- ₹187.0 Cr
- Revenue (annual)
- ₹65.12 Cr
- Net profit (annual)
- ₹13.14 Cr
- P/E (TTM)
- 14.2×Sector 23.6×
- Promoter holding
- 58.98%
- FII holding
- 1.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from EverestIMS Technologies Ltd
All →EverestIMS Technologies Board Meeting Date
Everestims' board meets 13 November 2026 to consider half-year standalone and consolidated results. Trading window closed since 8 October.
EverestIMS Technologies Management Change
EverestIMS discloses that Whole-Time Director Arun Prasath Ramadoss will step down from the executive role. He continues as Non-Executive Non-Independent Director from January 28, 2027.
EverestIMS Technologies Other Announcement
EverestIMS entered an investor relations advisory agreement with Finportal Investments. Consideration is Rs 8 lakh per year for twelve months, excluding taxes and expenses.
- Value
- ₹0.08 Cr
- Execution
- 12 months from October 28, 2026
EverestIMS Technologies Other Announcement
Everestims Technologies Ltd filed its quarterly shareholding pattern in compliance with SEBI regulations, disclosing the distribution of equity stakes among promoters and public shareholders.
Other other announcement announcements
All →Neueon Corporation Other Announcement
Neueon Corporation's members approved amendments to its Articles of Association via postal ballot, now approved by the Registrar of Companies. The amendment allows the Board to make multiple calls on partly paid shares.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals filed its RTA report for October 2026 on re-lodgement of physical share transfers. All request counts for the month are NIL.
Leapfrog Engineering Services Other Announcement
Leapfrog Engineering received a Trade Mark registration certificate for building construction services in Class 37. The registration discloses no monetary value or business impact.
Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Vinyas Innovative Technologies Other Announcement
Vinyas Innovative filed CRISIL's monitoring agency report for the quarter ended 30 September 2026. It reports no deviation from objects for its preferential warrant issue proceeds.
Parag Milk Foods Other Announcement
Sixth Sense India Opportunities III sold 43,842 shares on NSE for about Rs 1.45 Crore. Its stake fell from 1.44% to 1.40%.
- Value
- ₹1.45 Cr